File Download
  Patent History
  • Application
    US 12/4485206 2014-09-12
  • Granted
    US 20150071933 2015-03-12
  Patent Family

granted patent: Use of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma

TitleUse of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma
Granted PatentUS 20150071933
Granted Date2015-03-12
Priority Date2014-09-12 US 12/4485206
2013-09-12 US 12/1877061P
Inventors
Issue Date2015
Citation
US Patent US 20150071933. Washington, DC: US Patent and Trademark Office (USPTO), 2015 How to Cite?
AbstractAnnexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance.
Persistent Identifierhttp://hdl.handle.net/10722/210549

 

DC FieldValueLanguage
dc.date.accessioned2015-06-17T07:04:26Z-
dc.date.available2015-06-17T07:04:26Z-
dc.date.issued2015-
dc.identifier.citationUS Patent US 20150071933. Washington, DC: US Patent and Trademark Office (USPTO), 2015-
dc.identifier.urihttp://hdl.handle.net/10722/210549-
dc.description.abstractAnnexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance.-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleUse of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma-
dc.typePatent-
dc.identifier.authorityMA STEPHANIE KWAI YEE=rp00506-
dc.identifier.authorityGUAN XIN-YUAN=rp00454-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorGUAN XIN-YUAN-
dc.contributor.inventorMA STEPHANIE KWAI YEE-
dc.contributor.inventorTONG MAN-
patents.identifier.applicationUS 12/4485206-
patents.identifier.grantedUS 20150071933-
patents.description.assigneeUNIV HONG KONG [CN] -
patents.description.countryUnited States of America -
patents.date.granted2015-03-12-
patents.identifier.hkutechidOnco-2013-00467-1-
patents.date.application2014-09-12-
patents.date.priority2014-09-12 US 12/4485206-
patents.date.priority2013-09-12 US 12/1877061P-
patents.description.ccus-
patents.relation.familyWO 2015035941 (A1) 2015-03-19-
patents.description.kindA1-
patents.typePatent_granted-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats